Pall And FDA Will Discuss Studies To Support Prion Disease Filter Approval
This article was originally published in The Gray Sheet
Executive Summary
Pall Corp. plans to meet with FDA before the end of the year to discuss what studies will be necessary to approve its prion filtration system for blood transfusion processing, the firm says